Skip to main content
. 2016 Dec 8;9:10.3402/gha.v9.32505. doi: 10.3402/gha.v9.32505

Table 6.

Main findings of studies included in this review, presented based on the determinants of access to medication among diabetic patients

Determinants Authors Country (years) Study design Main findings
Place of residence Ben Romdhane et al. Tunisia (2014) Quantitative The proportion of those who were aware of having diabetes and untreated in urban and rural areas was 11.9 and 11%, respectively (p>0.05).
Cunningham-Myrie et al. Jamaica (2013) Quantitative 94.2% of people with diabetes in rural areas were treated, compared to 93.8% in urban areas
Balabanova et al. Georgia (2008) Qualitative Access to insulin was a problem in rural areas.
Kolling et al. Tanzania (2010) Qualitative Access to diagnosis and treatment was a problem in rural areas.
Kühlbrandt et al. Armenia, Belarus, Moldova, and Ukraine (2014) Qualitative Patients in rural areas were disadvantaged in accessing health facilities for screening and treatment by medical professional.
Rutebenberwa et al. Uganda (2013) Qualitative Patients who had geographical barrier to access health facilities substitute their medication with herbal medication.
Racial/ethnic Le et al. Yunan, China (2011) Quantitative The minority ethnic group had lower probability to be treated compared to Han (OR=0.26; 95% CI=0.09; 0.73).
Chary et al. Guatemala (2012) Qualitative In general, indigenous workers received lower payment than other workers. This affected their ability to buy medication for treating DM.
Occupation Ben Romdhane et al. Tunisia (2014) Quantitative There is no significant association between type of occupation and probability for being untreated.
Gender Ben Romdhane et al. Tunisia (2014) Quantitative 13% of women were untreated compared to 9.6% of men.
Stephens et al. 15 LMICs (2013) Quantitative In Brazil, use of newer drugs were more prevalent for men than women (p<0.01).
Cunningham-Myrie et al. Jamaica (2013) Quantitative There were more women who were treated (95%) compared to men (90.5%).
Gakidou et al. Colombia (2007) Quantitative 16.7% of women and 10% of men who had diabetes were untreated.
Iran (2004) Quantitative 11.5% of women and 12.5% of men who had diabetes were untreated.
Mexico (1994) Quantitative 2% of women and 4.7% of men who had diabetes were untreated.
Thailand (2008) Quantitative 3.2% of women and 8.1% of men who had diabetes were untreated.
Le et al. Yunan, China (2011) Quantitative 17.2% of men and 26.3% of women who had diabetes were treated.
Bhojani et al. India (2013) Qualitative Domestic roles had restricted women’s access to find medical treatment.
Religion No studies include religion as determinant of access to diabetes medication
Education Ben Romdhane et al. Tunisia (2014) Quantitative There is no significant association between level of education and being untreated.
Cunningham-Myrie et al. Jamaica (2013) Quantitative There was no significant association between level of education and being treated.
Le et al. Yunan, China (2011) Quantitative Patients who had primary (OR 2.91; 95% CI=1.69; 4.86) and middle/higher education (OR=2.72; 95% CI=1.22; 4.03) had higher probability to be treated with any DM medication compared to illiterate patients.
Socio-economic status/income Ben Romdhane et al. Tunisia (2014) Quantitative There are no significant association quintiles of household wealth and being untreated.
Baumann et al. Uganda (2010) Quantitative 37.9% had missed medication because they could not afford it.
Cunningham-Myrie et al. Jamaica (2013) Quantitative The proportion of people being treated was higher for higher-level income (100%) compared to those with middle-level (92.1%) and lower-level income (91.9%), p>0.05.
Le et al. Yunan, China (2011) Quantitative Those who were categorised as high-income group had higher probability than those in the low-income group (OR=2.92; 95% CI=1.64; 5.57).
Bhojani et al. India (2013) Qualitative Financial hardships affected people’s access to DM medication. Some of patients reduced their medication dosage or mixed with traditional medication to reduce medication cost.
Chary et al. Guatemala (2012) Qualitative Among the poor patients, cost of medication is a major barrier for being treated. Some of them bought the prescribed medication only when the household income allowed.
Higuchi The Philippines (2010) Qualitative Patients expressed financial constraint as major barriers to access or continue DM medication.
Balabanova et al. Georgia (2008) Qualitative Out-of-pocket payments for insulin acted as a significant barrier to access DM medication.
Kolling et al. Tanzania (2010) Qualitative Many poor patients were unable to purchase medication.
Kühlbrandt et al. Armenia, Belarus, Moldova, and Ukraine (2014) Qualitative Out-of-pocket payment for medication was a major barrier for the poor to access medication.
Rutebenberwa et al. Uganda (2013) Qualitative Patients substituted the medication with herbs because medication was not affordable.
Belue et al. Mbour, Senegal (2012) Qualitative It is hard for poor patients to get their diabetes treated.
Social capital Bhojani et al. India (2013) Qualitative Inadequate communication between providers and patients, patients’ negative attitude towards providers, and fragmented nature of health system had limited patient access to medication.
Higuchi The Philippines (2010) Qualitative Limited local government commitment and budget has affected on low drug availability in public facilities.
Kolling et al. Tanzania (2010) Qualitative Patients drew supports from their social networks within their local communities to support their medication.
Kühlbrandt et al. Armenia, Belarus, Moldova, and Ukraine (2014) Qualitative Poorer regions cannot afford to provide free medication. Hence those who resided in those regions had more financial barriers in accessing medication.
Rutebenberwa et al Uganda (2013) Qualitative Trust to traditional healer increased the tendency of patients to use herbal medication.
Belue et al. Mbour, Senegal (2012) Qualitative Extended family and the financial systems were associated with diabetes management.
Age Ben Romdhane et al. Tunisia (2014) Quantitative While it is non-linear, older people with diabetes has lower probability to be untreated compare to those aged 35–39 years old.
Le et al. Yunan, China (2011) Quantitative Across the age groups, the lowest proportion of people being treated was found in 18–34 years old (5.2%), while the highest prevalence was among those aged 45–54 years old (32.4%).
Higuchi The Philippines (2010) Qualitative Older patients had less financial support for medication.
Balabanova et al. Georgia (2008) Qualitative Medication cost is particularly a burden for older people.
Physical condition Kolling et al. Tanzania (2010) Qualitative Patients with poor physical condition experienced worse financial constrain to afford medication.
Health insurance Sosa-Rubi et al. Mexico (2009) Quantitative Those who were insured used more insulin per week than those who were not covered by health insurance (13 vs. 9, p>0.05).
Cunningham-Myrie et al. Jamaica (2013) Quantitative 100% of people who had health insurance were treated compared to 92.4% of those who had no health insurance.
Belue et al. Mbour, Senegal (2012) Qualitative Health insurance could benefit access to medication.

DM, diabetes mellitus; LMICs, low- and middle-income countries.